“Deferasirox on COVID-19: safety and efficacy of iron-chelating therapy. A multicentric, randomized, triple blinded study”, PPCR, vol. 7, no. 4, pp. 38–46, Jan. 2022, doi: 10.21801/ppcrj.2021.74.5.